Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-07-12

Clinical Trial Update: Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing permanent versus frozen section pathological control for periocular basal cell carcinoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Queen's University | Conditions: Basal Cell Carcinoma | Phase 3 | Status: UNKNOWN